TECX (Tectonic Therapeutic) Stock Based Compensation : $5.27 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Tectonic Therapeutic Stock Based Compensation?

Tectonic Therapeutic's Stock Based Compensation for the three months ended in Mar. 2025 was $2.10 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was $5.27 Mil.

Tectonic Therapeutic Stock Based Compensation Historical Data

The historical data trend for Tectonic Therapeutic's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tectonic Therapeutic Stock Based Compensation Chart

Tectonic Therapeutic Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Stock Based Compensation

0.64

1.12

3.49

Tectonic Therapeutic Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Stock Based Compensation	Get a 7-Day Free Trial					0.32	0.40	1.65	1.12	2.10

Tectonic Therapeutic Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.27 Mil.

Tectonic Therapeutic Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Tectonic Therapeutic's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tectonic Therapeutic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472

Website

https://www.tectonictx.com

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.